Medicis Pharmaceutical Corp. (MRX) Tops Q1 EPS by 14c

Go back to Medicis Pharmaceutical Corp. (MRX) Tops Q1 EPS by 14c

Marex Group PLC (MRX) PT Raised to $58 at Citi

May 15, 2025 1:31 PM EDT

Citi analyst Chris Allen raised the price target on Marex Group PLC (NASDAQ: MRX) to $58.00 (from $50.00) while maintaining a Buy rating.

The analyst comments "In 1Q, MRX continued to see strong momentum across its businesses, driven by strong client activity across the platform given... More